Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake

Abstract Background Tumor to normal tissue ratio (T/N ratio) on 11C-methionine (11C-MET) positron emission tomography/computed tomography (PET/CT) is affected by variable factors. We investigated whether T/N ratio cutoff values corrected according to metabolic tumor volume (MTV) could improve the di...

Full description

Bibliographic Details
Main Authors: Tae-Young Jung, In-Young Kim, Sa-Hoe Lim, Ki Seong Park, Dong-Yeon Kim, Shin Jung, Kyung-Sub Moon, Woo-Youl Jang, Sae-Ryung Kang, Sang-Geon Cho, Jung-Joon Min, Hee-Seung Bom, Seong Young Kwon
Format: Article
Language:English
Published: SpringerOpen 2017-05-01
Series:EJNMMI Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13550-017-0293-0
_version_ 1818323849456910336
author Tae-Young Jung
In-Young Kim
Sa-Hoe Lim
Ki Seong Park
Dong-Yeon Kim
Shin Jung
Kyung-Sub Moon
Woo-Youl Jang
Sae-Ryung Kang
Sang-Geon Cho
Jung-Joon Min
Hee-Seung Bom
Seong Young Kwon
author_facet Tae-Young Jung
In-Young Kim
Sa-Hoe Lim
Ki Seong Park
Dong-Yeon Kim
Shin Jung
Kyung-Sub Moon
Woo-Youl Jang
Sae-Ryung Kang
Sang-Geon Cho
Jung-Joon Min
Hee-Seung Bom
Seong Young Kwon
author_sort Tae-Young Jung
collection DOAJ
description Abstract Background Tumor to normal tissue ratio (T/N ratio) on 11C-methionine (11C-MET) positron emission tomography/computed tomography (PET/CT) is affected by variable factors. We investigated whether T/N ratio cutoff values corrected according to metabolic tumor volume (MTV) could improve the diagnostic performance of 11C-MET PET/CT for diagnosis of recurrence in patients with metastatic brain tumor. Forty-eight patients with metastatic brain tumors underwent 11C-MET PET/CT for differential diagnosis between recurrence and radiation necrosis after gamma knife radiosurgery (GKR). Both T/N ratio and MTV were estimated in each lesion on 11C-MET PET/CT. The lesions were classified into three groups based on MTV criteria (≤ 0.5 cm3; > 0.5, ≤ 4.0 cm3; and > 4.0 cm3). The optimal cutoff values of the T/N ratio from receiver operating characteristic (ROC) curve were determined in each group (MTV-corrected) as well as total lesions (non-corrected). Finally, diagnostic performance of 11C-MET PET/CT was compared with the MTV-corrected cutoff values. Results Among 77 lesions, 51 were diagnosed with recurrence. The mean T/N ratio was 2.25 (± 1.12) for recurrent lesions and 1.44 (± 0.22) for radiation necrosis (P < 0.001). T/N ratio of 1.61 (non-corrected) provided the best sensitivity, specificity, and diagnostic accuracy (70.6, 80.8, and 74.0%, respectively). Using the MTV criteria, optimal cutoff values of the T/N ratios in each group were 1.23 (MTV ≤ 0.5 cm3), 1.54 (0.5 cm3 < MTV ≤ 4.0 cm3), and 1.85 (MTV > 4.0 cm3). In small-sized lesions (MTV ≤ 0.5 cm3), MTV-corrected cutoff values (1.23) could maintain favorable diagnostic performance with sensitivity, specificity, and diagnostic accuracy (70.0, 80.0, and 73.3%, respectively), compared to non-corrected cutoff values. Conclusions MTV-corrected cutoff values of T/N ratio could maintain the diagnostic performance of 11C-MET PET/CT in small sized, metastatic brain tumors. We expect our results to contribute to reproducible and standardized interpretation of 11C-MET PET/CT.
first_indexed 2024-12-13T11:19:14Z
format Article
id doaj.art-fa40f4657ed94916b6b0e58b1378b623
institution Directory Open Access Journal
issn 2191-219X
language English
last_indexed 2024-12-13T11:19:14Z
publishDate 2017-05-01
publisher SpringerOpen
record_format Article
series EJNMMI Research
spelling doaj.art-fa40f4657ed94916b6b0e58b1378b6232022-12-21T23:48:33ZengSpringerOpenEJNMMI Research2191-219X2017-05-01711610.1186/s13550-017-0293-0Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptakeTae-Young Jung0In-Young Kim1Sa-Hoe Lim2Ki Seong Park3Dong-Yeon Kim4Shin Jung5Kyung-Sub Moon6Woo-Youl Jang7Sae-Ryung Kang8Sang-Geon Cho9Jung-Joon Min10Hee-Seung Bom11Seong Young Kwon12Department of Neurosurgery, Chonnam National University Hwasun HospitalDepartment of Neurosurgery, Chonnam National University Hwasun HospitalDepartment of Neurosurgery, Chonnam National University Hwasun HospitalDepartment of Nuclear Medicine, Chonnam National University Hwasun HospitalDepartment of Nuclear Medicine, Chonnam National University Hwasun HospitalDepartment of Neurosurgery, Chonnam National University Hwasun HospitalDepartment of Neurosurgery, Chonnam National University Hwasun HospitalDepartment of Neurosurgery, Chonnam National University Hwasun HospitalDepartment of Nuclear Medicine, Chonnam National University Hwasun HospitalDepartment of Nuclear Medicine, Chonnam National University Hwasun HospitalDepartment of Nuclear Medicine, Chonnam National University Hwasun HospitalDepartment of Nuclear Medicine, Chonnam National University Hwasun HospitalDepartment of Nuclear Medicine, Chonnam National University Hwasun HospitalAbstract Background Tumor to normal tissue ratio (T/N ratio) on 11C-methionine (11C-MET) positron emission tomography/computed tomography (PET/CT) is affected by variable factors. We investigated whether T/N ratio cutoff values corrected according to metabolic tumor volume (MTV) could improve the diagnostic performance of 11C-MET PET/CT for diagnosis of recurrence in patients with metastatic brain tumor. Forty-eight patients with metastatic brain tumors underwent 11C-MET PET/CT for differential diagnosis between recurrence and radiation necrosis after gamma knife radiosurgery (GKR). Both T/N ratio and MTV were estimated in each lesion on 11C-MET PET/CT. The lesions were classified into three groups based on MTV criteria (≤ 0.5 cm3; > 0.5, ≤ 4.0 cm3; and > 4.0 cm3). The optimal cutoff values of the T/N ratio from receiver operating characteristic (ROC) curve were determined in each group (MTV-corrected) as well as total lesions (non-corrected). Finally, diagnostic performance of 11C-MET PET/CT was compared with the MTV-corrected cutoff values. Results Among 77 lesions, 51 were diagnosed with recurrence. The mean T/N ratio was 2.25 (± 1.12) for recurrent lesions and 1.44 (± 0.22) for radiation necrosis (P < 0.001). T/N ratio of 1.61 (non-corrected) provided the best sensitivity, specificity, and diagnostic accuracy (70.6, 80.8, and 74.0%, respectively). Using the MTV criteria, optimal cutoff values of the T/N ratios in each group were 1.23 (MTV ≤ 0.5 cm3), 1.54 (0.5 cm3 < MTV ≤ 4.0 cm3), and 1.85 (MTV > 4.0 cm3). In small-sized lesions (MTV ≤ 0.5 cm3), MTV-corrected cutoff values (1.23) could maintain favorable diagnostic performance with sensitivity, specificity, and diagnostic accuracy (70.0, 80.0, and 73.3%, respectively), compared to non-corrected cutoff values. Conclusions MTV-corrected cutoff values of T/N ratio could maintain the diagnostic performance of 11C-MET PET/CT in small sized, metastatic brain tumors. We expect our results to contribute to reproducible and standardized interpretation of 11C-MET PET/CT.http://link.springer.com/article/10.1186/s13550-017-0293-011C-methionine PET/CTMetabolic tumor volumeMetastatic brain tumorRecurrenceRadiation necrosis
spellingShingle Tae-Young Jung
In-Young Kim
Sa-Hoe Lim
Ki Seong Park
Dong-Yeon Kim
Shin Jung
Kyung-Sub Moon
Woo-Youl Jang
Sae-Ryung Kang
Sang-Geon Cho
Jung-Joon Min
Hee-Seung Bom
Seong Young Kwon
Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake
EJNMMI Research
11C-methionine PET/CT
Metabolic tumor volume
Metastatic brain tumor
Recurrence
Radiation necrosis
title Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake
title_full Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake
title_fullStr Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake
title_full_unstemmed Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake
title_short Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake
title_sort optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume corrected 11c methionine uptake
topic 11C-methionine PET/CT
Metabolic tumor volume
Metastatic brain tumor
Recurrence
Radiation necrosis
url http://link.springer.com/article/10.1186/s13550-017-0293-0
work_keys_str_mv AT taeyoungjung optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT inyoungkim optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT sahoelim optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT kiseongpark optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT dongyeonkim optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT shinjung optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT kyungsubmoon optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT wooyouljang optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT saeryungkang optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT sanggeoncho optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT jungjoonmin optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT heeseungbom optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake
AT seongyoungkwon optimizationofdiagnosticperformancefordifferentiationofrecurrencefromradiationnecrosisinpatientswithmetastaticbraintumorsusingtumorvolumecorrected11cmethionineuptake